[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2006, 32(5) 297-299 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||
CD40-CD40L��Ƥ���� | |||||||||||||||||||||||||||||||||||||||||||||||
�콡ΰ, �浤 | |||||||||||||||||||||||||||||||||||||||||||||||
�Ͼ�ҽ�ƴ�ѧ��һ����ҽԺƤ����, 210029 | |||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
CD40�����ܱ���ڶ���ϸ���ı���,��������Ȼ����CD40L�����ڽ鵼����ϸ���ij��졢�������ЧӦ��������Ҫ���á�CD40-CD40L�ź�ת��;�����쳣���»���������������߷�Ӧ����Ƥ��������,CD40-CD40L����ò����˻��������ԡ���֢�ԡ���Ⱦ�Լ�������Ƥ�����ķ����ͷ�չ�� | |||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� CD40 CD40���� Ƥ������ | |||||||||||||||||||||||||||||||||||||||||||||||
CD40-CD40L and Skin Diseases | |||||||||||||||||||||||||||||||||||||||||||||||
Department of Dermatology, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China | |||||||||||||||||||||||||||||||||||||||||||||||
Department of Dermatology, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China | |||||||||||||||||||||||||||||||||||||||||||||||
Abstract:
As a surface antigen, CD40 is expressed on many kinds of cells, and the binding of it with its natural ligand CD40L plays important roles in the mediation of maturation, activation, and exertion of immunological effect of immunocompetant cells. The abnormity of CD40-CD40L signal pathway will result in pathological immunoreactions. In dermatology field, the interaction of CD40-CD40L is involved in the occurrence and development of immunologic, inflammatory, infectious and tumorous dermatoses. | |||||||||||||||||||||||||||||||||||||||||||||||
Keywords: CD40 CD40 ligand Skin diseases | |||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2006-03-28 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||
[1] Concha M,Vidal MA,Moreno I,et al.Evidence for modulation of human epidermal differentiation and remodelling by CD40.Br J Dermatol,2003,148:1105-1114. [2] Grousson J,Ffrench M,Concha M,et al.CD40 ligation alters the cell cycle of differentiating keratinocytes.J Invest Dermatol,2000,114:581-586. [3] Companjen AR,van der Wel LI,Boon L,et al.CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1.Int Immunol,2002,14:669-676. [4] Mehling A,Loser K,Varga G,et al.Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.J Exp Med,2001,194:615-628. [5] Singh SR,Casper K,Summers S,et al.CD40 expression and function on human dermal microvascular endothelial cells:role in cutaneous inflammation.Clin Exp Dermatol,2001,26:434-440. [6] Katsiari CG,Liossis SN,Souliotis VL,et al.Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.Clin Immunol,2002,103:54-62. [7] Delmas Y,Viallard JF,Solanilla A,et al.Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.Kidney Int,2005,68:2068-2078. [8] Fukasawa C,Kawaguchi Y,Harigai M,et al.Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis(SSc):role of CD40-CD154 in the phenotype of SSc fibroblasts.Eur J Immunol,2003,33:2792-2800. [9] Caproni M,Torchia D,Cardinali C,et al.Infiltrating cells,related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis.Br J Dermatol,2004,151:784-791. [10] Ohta Y,Hamada Y.In situ Expression of CD40 and CD40 ligand in psoriasis.Dermatology,2004,209:21-28. [11] Pasch MC,Timar KK,van Meurs M,et al.In situ demonstration of CD40-and CD154-positive cells in psoriatic lesions and keratinocyte production ofchemokines by CD40 ligation in vitro.J Pathol,2004,203:839-848. [12] Gorbachev AV,Fairchild RL.CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.J Immunol,2004,173:2443-2452. [13] Watanabe N,Hanabuchi S,Marloie-Provost MA,et al.Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential.Blood,2005,105:4749-4751. [14] Polak ME,Johnson P,Di Palma S,et al.Presence and maturity of dendritic cells in melanoma lymph node metastases.J Pathol,2005,207:83-90. [15] Kooy AJ,Prens EP,Van Heukelum A,et al.Interferon-gamma-induced ICAM-1 and CD40 expression,complete lack of HLA-DR and CD80 (B7.1),and inconsistent HLA-ABC expression in basal cell carcinoma:a possible role for interleukin-10? J Pathol,1999,187:351-357. [16] Storz M,Zepter K,Kamarashev J,et al.Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides).Cancer Res,2001,61:452-454. |
|||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||
1���콡ΰ �浤.CD40-CD40L��Ƥ����[J]. ����Ƥ���Բ�ѧ��־, 2006,32(5): 297-297 | |||||||||||||||||||||||||||||||||||||||||||||||
2������������, ��־ǿ��У, ��������У.CD40/CD40��������ߵ�����ϵͳ�Ժ���Ǵ�[J]. ����Ƥ���Բ�ѧ��־, 2000,26(6): 336-339 | |||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |